SRTOY (Sartorius Stedim Biotech) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SRTOY Sartorius Stedim Biotech SA SRTOY
82 GF Score
Price $21.72
GF Value $23.81
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Sartorius Stedim Biotech Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

SRTOY
82GF Score
Sartorius Stedim Biotech SA SRTOY
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sartorius Stedim Biotech (SRTOY) Overvalued in 2026?

Based on GuruFocus' analysis, Sartorius Stedim Biotech stock appears to be undervalued. The current stock price of $21.72 is trading 8.8% below its estimated GF Value™ of $23.81. GuruFocus considers Sartorius Stedim Biotech to be Fairly Valued.

Key valuation signals for SRTOY:

  • Dividends Received:
  • GF Value™: $23.81 vs. price of $21.72 (8.8% below fair value)
  • GF Score™: 82/100 with 5 warning signs

No single metric tells the full story. See the SRTOY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sartorius Stedim Biotech Business Description

Address Otto-Brenner-Strasse 20, Goettingen, DEU, 37079
Sartorius Stedim Biotech is a leading provider of bioprocessing solutions. It sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs and has a focus on single-use technology. It is a subsidiary of Sartorius AG, which has 71.5% ownership and 83% voting control. The business is geographically diverse, with 35% of sales from the Americas, 42% from Europe, the Middle East, and Africa, 15% from Asia excluding China, and 8% from China.
82GF Score

Get the complete analysis for SRTOY

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$21.72
Price
$23.81
GF Value